PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED RECURRENT

This adverse event was reported 67 times

These drugs are most commonly taken by patients reporting PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED RECURRENT:

# Drug Count
0 BELINOSTAT 15
1 PREDNISONE 15
2 CYCLOPHOSPHAMIDE 13
3 CYCLOPHOSPHAMIDE FOR INJECTION 13
4 CYCLOPHOSPHAMIDE INJECTION, SOLUTION 13
5 ETOPOSIDE 11
6 PRALATREXATE 11
7 BRENTUXIMAB VEDOTIN 10
8 DOXORUBICIN 10
9 CYCLOSPORINE 8
See all common drugs associated with PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED RECURRENT

PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED RECURRENT is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 BELINOSTAT 15 0.0419
1 PRALATREXATE 11 0.0169
2 PALIFERMIN 1 0.0026
3 ROMIDEPSIN 2 0.0012
4 DUVELISIB 1 0.0012
5 BRENTUXIMAB VEDOTIN 10 0.0010
6 VORINOSTAT 2 0.0009
7 EPINASTINE HYDROCHLORIDE 1 0.0009
8 FLECAINIDE ACETATE 3 0.0006
9 CARMUSTINE 2 0.0004
See all drugs enriched for association with PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED RECURRENT